Federal contractors / CANGENE CORPORATION

Federal contract award

HHSO100200600017C

TAS::75 XXXX::TAS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS325414 — Biological Product (except Diagnostic) Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$510.9M
Current contract value$510.9M
Potential contract value / ceiling$594.2M
Start dateMay 30, 2006
Current end dateDec 31, 2027
Potential end dateDec 31, 2027
Latest award activityMar 31, 2023
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 47 of 47 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 31, 2023P00046$1.0MADD FUNDING.
Sep 30, 2022P00045$6.6MADD FUNDING, SUBCLIN FOR BROKEN OUT WORK, AND DOCUMENT AN INVOICING ERROR THAT EMERGENT RELINQUISHES ANY CLAIMS TO UPON SIGNATURE OF THIS MODIFICATION.
Jan 25, 2022P00044$0ADMINISTRATIVE CHANGES - UPDATES TO CONTRACTING OFFICER'S REPRESENTATIVE
Nov 30, 2021P00043$0ADMINISTRATIVE CHANGES - UPDATES TO CONTRACTING OFFICER'S REPRESENTATIVE
May 13, 2021P00042$0ADMINISTRATIVE CHANGES - UPDATES TO CONTRACTING OFFICER'S REPRESENTATIVE
Oct 21, 2020P00041$0ADMINISTRATIVE CHANGES - UPDATES TO THE CONTRACT OFFICER REPRESENTATIVE
Aug 3, 2020P00040$0ADMINISTRATIVE CHANGES - UPDATES TO THE CONTRACTING OFFICER&CONTRACT OFFICER REPRESENTATIVE
Dec 3, 2019P00039$0REDUCTION OF 1 HORSE, EXTENSION OF POP OF CLIN 10B(B) TO DECEMBER 31, 2022.
May 30, 2019P00038$0IGF::CL::IGF
Dec 18, 201837$0IGF::CL::IGF
Nov 15, 201736$0IGF::CL::IGF
Apr 19, 201735$0IGF::CL::IGF
Mar 22, 201734$53.3MIGF::CL::IGF
Dec 9, 201633$0IGF::CL::IGF
Jun 13, 201632$18.5MIGF::CL::IGF
Jun 4, 201531$0IGF::CL::IGF
Jan 14, 201530$0IGF::CL::IGF
Dec 11, 201429$0IGF::CL::IGF
Sep 24, 201428$4.0MIGF::CL::IGF
Jul 28, 201427$0IGF::CL::IGF
Jul 16, 201426$0IGF::CL::IGF
May 28, 201425$0IGF::CL::IGF
Jan 15, 201424$0IGF::CL::IGF
Jul 25, 201323$0IGF::CL::IGF
Sep 27, 201222$0IGF::CL::IGF
Jul 1, 201121$61.1MDRUGS AND BIOLOGICALS
Jun 29, 201119$0DRUGS AND BIOLOGICALS
Jun 29, 201120$0DRUGS AND BIOLOGICALS
Jul 9, 201018$0DRUGS AND BIOLOGICALS
Apr 16, 201017$0TAS::75 XXXX::TAS
Mar 26, 201016$0TAS::75 XXXX::TAS
Oct 9, 200915$0TAS::75 XXXX::TAS
Jul 13, 200914$0DRUGS AND BIOLOGICALS
May 7, 200913$0DRUGS AND BIOLOGICALS
Feb 2, 200912$0DRUGS AND BIOLOGICALS
Sep 30, 200811$0DRUGS AND BIOLOGICALS
Jun 20, 200810$0DRUGS AND BIOLOGICALS
Apr 10, 20089$0DRUGS AND BIOLOGICALS
Mar 31, 20088$0DRUGS AND BIOLOGICALS
Feb 1, 20087$0DRUGS AND BIOLOGICALS
Nov 16, 20076$0DRUGS AND BIOLOGICALS
Jun 22, 20075$0DRUGS AND BIOLOGICALS
Jun 15, 20074$0DRUGS AND BIOLOGICALS
Feb 1, 20073$1.7MTAS::75 XXXX::TAS
Nov 8, 20062$0DRUGS AND BIOLOGICALS
Jul 18, 20061$2.0MTAS::75 XXXX::TAS
May 30, 20060$362.6MTAS::75 XXXX::TAS

Estimated positioning window

Dec 31, 2026 – Jun 30, 2027

Recompete signal:
65/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 65/100. Available recorded signals: 60 points.

Contract end 2027-12-31 (432 days from calculation)
+25 points
29 historical awards in this buyer and category group
+15 points
47 recorded award transactions
+10 points
Latest award action: 2023-03-31
+0 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.